Dr. Reddy’s buys Progynova and Cyclo-Progynova brands from Mercury Pharma for $32.15M to enter India’s HRT market.

The 5th HOSPEX Healthcare Expo 2026 opens Feb 20 in Ahmedabad, India, showcasing medical tech innovations and attracting global visitors.

FDA accepts Teva's application for monthly injectable schizophrenia drug.

Obefazimod shows promise for Crohn’s and colitis, reducing fibrosis and inducing remission by week 2 with a safe profile.

CEO Marshall Perkins boosted his stake in MDCE to 66.2M shares via open-market buys at $0.0002, affirming confidence in the company’s AI medical screening strategy.

Eli Lilly's 2025 success driven by diabetes and weight-loss drugs, with key drug advances and major AI investments.

A new TB treatment shows better results and safety than standard therapy in a recent trial.

A 68-year-old Mississippi woman with early Alzheimer’s is using LEQEMBI to slow decline, emphasizing early diagnosis and family.

A rare pancreatic tumor was successfully treated at Kauvery Hospital in India using advanced medical technology.

Arrowhead Pharmaceuticals beat revenue estimates with $264M in Q1 2026 and was added to S&P 400 indices as lock-up on insider shares ends.